rs200862250

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_031206.7(LAS1L):​c.1735G>A​(p.Val579Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000454 in 1,201,865 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 169 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., 4 hem., cov: 24)
Exomes 𝑓: 0.00048 ( 0 hom. 165 hem. )

Consequence

LAS1L
NM_031206.7 missense

Scores

1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: -0.388

Publications

2 publications found
Variant links:
Genes affected
LAS1L (HGNC:25726): (LAS1 like ribosome biogenesis factor) Enables RNA binding activity. Predicted to be involved in maturation of 5.8S rRNA and maturation of LSU-rRNA. Located in membrane. Part of MLL1 complex. Implicated in Wilson-Turner syndrome. [provided by Alliance of Genome Resources, Apr 2022]
LAS1L Gene-Disease associations (from GenCC):
  • Wilson-Turner syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P
  • spinal muscular atrophy with respiratory distress type 2
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked syndromic intellectual disability
    Inheritance: XL Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.021074593).
BP6
Variant X-65518179-C-T is Benign according to our data. Variant chrX-65518179-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 464822.
BS2
High Hemizygotes in GnomAd4 at 4 Unknown,XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAS1LNM_031206.7 linkc.1735G>A p.Val579Ile missense_variant Exon 12 of 14 ENST00000374811.8 NP_112483.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAS1LENST00000374811.8 linkc.1735G>A p.Val579Ile missense_variant Exon 12 of 14 1 NM_031206.7 ENSP00000363944.3

Frequencies

GnomAD3 genomes
AF:
0.000178
AC:
20
AN:
112046
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000944
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000163
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000280
AC:
51
AN:
182042
AF XY:
0.000268
show subpopulations
Gnomad AFR exome
AF:
0.0000760
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000134
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000596
Gnomad OTH exome
AF:
0.000221
GnomAD4 exome
AF:
0.000483
AC:
526
AN:
1089819
Hom.:
0
Cov.:
29
AF XY:
0.000464
AC XY:
165
AN XY:
355583
show subpopulations
African (AFR)
AF:
0.0000762
AC:
2
AN:
26243
American (AMR)
AF:
0.00
AC:
0
AN:
35202
Ashkenazi Jewish (ASJ)
AF:
0.0000517
AC:
1
AN:
19333
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53942
European-Finnish (FIN)
AF:
0.0000247
AC:
1
AN:
40504
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4113
European-Non Finnish (NFE)
AF:
0.000611
AC:
510
AN:
834468
Other (OTH)
AF:
0.000262
AC:
12
AN:
45830
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
22
44
65
87
109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000178
AC:
20
AN:
112046
Hom.:
0
Cov.:
24
AF XY:
0.000117
AC XY:
4
AN XY:
34208
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30783
American (AMR)
AF:
0.0000944
AC:
1
AN:
10592
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3571
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2690
European-Finnish (FIN)
AF:
0.000163
AC:
1
AN:
6124
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.000338
AC:
18
AN:
53204
Other (OTH)
AF:
0.00
AC:
0
AN:
1511
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000304
Hom.:
3
Bravo
AF:
0.000212
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000346
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000297
AC:
2
ExAC
AF:
0.000181
AC:
22
EpiCase
AF:
0.000545
EpiControl
AF:
0.000652

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Wilson-Turner syndrome Uncertain:1
May 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 579 of the LAS1L protein (p.Val579Ile). This variant is present in population databases (rs200862250, gnomAD 0.05%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with LAS1L-related conditions. ClinVar contains an entry for this variant (Variation ID: 464822). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LAS1L protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Benign:1
Dec 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LAS1L: BP4, BS2 -

Intellectual disability Benign:1
Jan 01, 2019
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.76
T
BayesDel_noAF
Benign
-0.98
CADD
Benign
2.0
DANN
Benign
0.22
DEOGEN2
Benign
0.025
.;T;.
FATHMM_MKL
Benign
0.049
N
LIST_S2
Benign
0.73
T;T;T
M_CAP
Benign
0.0079
T
MetaRNN
Benign
0.021
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
.;L;.
PhyloP100
-0.39
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.27
N;N;N
REVEL
Benign
0.010
Sift
Benign
0.76
T;T;T
Sift4G
Uncertain
0.052
T;T;T
Polyphen
0.0030
B;B;B
Vest4
0.050
MVP
0.37
MPC
0.57
ClinPred
0.0097
T
GERP RS
-1.6
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
3.2
Varity_R
0.038
gMVP
0.068
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200862250; hg19: chrX-64738059; API